CANDIECE NICOLE MILLER
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant OKLAHOMA CITY, OK NPI 1639155385
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant OK GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$262.57
- Category: General Payments
- Program years: PY2022–2023
- Record count: 11
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $132.76 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $132.76 | 7 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $37.94 | 2 |
| Acerta Pharma LLC | $34.49 | 2 |
| Janssen Biotech, Inc. | $33.26 | 2 |
| GENZYME CORPORATION | $27.07 | 1 |
By program year
Records — PY2023 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1003769521 | GlaxoSmithKline, LLC. | $20.89 | 09/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1003769527 | GlaxoSmithKline, LLC. | $17.05 | 11/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1012115073 | AstraZeneca Pharmaceuticals LP | $16.66 | 10/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015867869 | AstraZeneca Pharmaceuticals LP | $17.83 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1050294763 | GENZYME CORPORATION | $27.07 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 988495925 | Janssen Biotech, Inc. | $17.42 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 988495935 | Janssen Biotech, Inc. | $15.84 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.